COURSE DESCRIPTION
This webinar focuses on APOL1-Mediated Kidney Disease. AMKD is a genetic condition responsible for a substantial portion of excess kidney disease suffered by African Americans, presenting from early onset nephrotic syndrome to what we have mislabeled "hypertensive" chronic kidney disease. Understanding of AMKD casts new light on kidney disease disparities and illuminates the path to precision medicine.The content and financial support of this webinar is provided by Vertex Pharmaceuticals. RPA does not endorse this webinar nor endorse or promote any specific commercial entities or products.
FEES
RPA MemberComplimentary
Non-Member
Complimentary
CREDIT HOURS
None available.WHO WILL BENEFIT
Nephrology PractitionersPRESENTERS
Speaker: Margaret B. Collins, MD,FASHNephrologist and Hypertension Specialist
AMKD Field Medical Director
Vertex